Intentar ORO - Gratis

Business

Bio Spectrum

Bio Spectrum

Brain health startup Ivory raises $1M in fresh funding

Mumbai-based Ivory, an early-stage brain health startup, has announced the successful close of its latest $1million funding round. The round was co-led by IIM-A Ventures, the entrepreneurship center at IIM Ahmedabad that incubates, accelerates and invests in early-stage technology startups, and Capital-A, a fund known for backing innovative early-stage startups, which had previously backed Ivory in the pre-seed stage.

1 min  |

BioSpectrum India June 2025
Bio Spectrum

Bio Spectrum

Sir H.N. Reliance Foundation Hospital ropes in breast surgeon Dr Ashutosh Kothari

World renowned breast surgeon Dr Ashutosh Kothari has joined Sir H.N. Reliance Foundation Hospital as Director — Breast Cancer, Oncoplastic & Reconstructive Surgery.

1 min  |

BioSpectrum India June 2025
Bio Spectrum

Bio Spectrum

Nandakumar Kalathil steps in as Country General Manager for Agilent India

Agilent has announced the appointment of Nandakumar (Nanda) Kalathil as the Country General Manager (CGM) for Agilent India.

1 min  |

BioSpectrum India June 2025

Bio Spectrum

PAHO & UNOPS to strengthen health systems in Latin America & the Caribbean

The United Nations Office for Project Services (UNOPS) and the Pan American Health.

1 min  |

BioSpectrum India June 2025

Bio Spectrum

Health Ministry unveils national zero MeaslesRubella elimination campaign

Union Minister of Health and Family Welfare, Jagat Prakash Nadda virtually launched the National Zero Measles-Rubella (MR) Elimination campaign 2025-26 on the first day of the World Immunisation Week (April 24-30), marking a significant step towards India's goal of eliminating MR by 2026.

1 min  |

BioSpectrum India June 2025
Bio Spectrum

Bio Spectrum

Indian research institutions and Oxford Nanopore to collaborate on genomic CoE

UK-based Oxford Nanopore Technologies, the global company behind a new generation of nanopore-based molecular sensing technology, has signed Letters of Intent with the Biotechnology Research and Innovation Council-Centre for DNA Fingerprinting and Diagnostics (BRIC-CDFD), and the Biotechnology Research and Innovation Council-National Institute of Biomedical Genomics (BRIC-NIBMG), which commit to the establishment of two new Indian Centres of Excellence (COE) in genomics.

1 min  |

BioSpectrum India June 2025
Bio Spectrum

Bio Spectrum

Angola commits $5 M to Africa CDC for health financing strategy

In a strong act of continental solidarity, João Lourenço, President of the Republic of Angola and Chairperson of the African Union, announced a landmark voluntary contribution of $5 million to the Africa Centres for Disease Control and Prevention (Africa CDC), reaffirming Angola's leadership and enduring commitment to strengthening regional health security and sustainable health financing.

1 min  |

BioSpectrum India June 2025
Bio Spectrum

Bio Spectrum

Zydus invests in Feldan Therapeutics to drive innovation in intracellular drug delivery

Zynext Ventures USA LLC, the venture capital arm of Ahmedabad-based Zydus Lifesciences, has announced its investment in Feldan Therapeutics, a Canada-based early clinical-stage pharmaceutical company pioneering the development of treatments based on intracellular delivery of therapeutics.

1 min  |

BioSpectrum India June 2025
Bio Spectrum

Bio Spectrum

TPG acquires 35% stake in Schott Poonawalla from Serum Institute of India

Schott Pharma, a pioneer in drug containment and delivery solutions, has announced that TPG, a leading global alternative asset management firm, has entered into a binding agreement to acquire a 35 per cent stake in its joint venture Schott Poonawalla from Serum Institute of India (SII).

1 min  |

BioSpectrum India June 2025
Bio Spectrum

Bio Spectrum

Shashvi Remedies secures Rs 10 lakh grant from Maharashtra State Innovation Society

Mumbai-based Shashvi Remedies, a pioneer in healthcare innovation, has received a grant of Rs 10 lakh for international patents from the Maharashtra State Innovation Society (MSINS) under the Government of Maharashtra's Skill Development and Entrepreneurship Department (SDED).

1 min  |

BioSpectrum India June 2025
Bio Spectrum

Bio Spectrum

Synergistic INDO-UK FTA

The trade tariff tussle between the US and India seems to have a good outcome. The recently concluded bilateral Free Trade Agreement (FTA) between India and the UK is probably an example of opening another door when one was shut.

2 min  |

BioSpectrum India June 2025
Bio Spectrum

Bio Spectrum

How AI is enhancing medical diagnostics

India's medical diagnostics sector is undergoing a transformative shift, fuelled by the power of Artificial Intelligence (AI). According to a report by Research and Markets, the AI-based Medical Diagnostics Market in India was valued at $12.87 million in 2024 and is projected to soar to $44.87 million by 2030, growing at an impressive CAGR of 23.1 per cent.

7 min  |

BioSpectrum India June 2025
Bio Spectrum

Bio Spectrum

UK's tech reform to transform cancer diagnosis

Millions of cancer patients will receive a faster diagnosis, helping cut treatment delays and boost survival rates as the UK government rolls out pioneering new technology across the National Health Service (NHS) through the Plan for Change.

1 min  |

BioSpectrum India June 2025
Bio Spectrum

Bio Spectrum

Leveraging Genomic Data

While the entire pharma world is still grappling with the issue of tariffs by the US and its impact on the US consumers as well as various other countries (though there is 90-day relief on the issue), India has achieved a significant step in the healthcare and medicines sector.

2 min  |

BioSpectrum India May 2025
Bio Spectrum

Bio Spectrum

Ensuring Biotech Startup Success Stories

According to the Indian BioEconomy Report 2025, the number of biotech startups has more than doubled from 4237 in 2020 to 10,075 in 2024.

4 min  |

BioSpectrum India May 2025
Bio Spectrum

Bio Spectrum

Unlocking Future of Large and Small Molecule Pharma R&D with Science-Driven Digital Solutions

As pharmaceutical companies expand their R&D operations globally, Indian Contract Development and Manufacturing Organisations (CDMOs) are attracting significant investment.

5 min  |

BioSpectrum India May 2025
Bio Spectrum

Bio Spectrum

Medical Device Classification and FDA Approva:What Startups Need to Know

For many innovators, the United States represents a key market, being the world’s largest for medical devices.

4 min  |

BioSpectrum India May 2025
Bio Spectrum

Bio Spectrum

BiomatiQ Inaugurates State-of-the-Art, Fully Automated Production Line for Ready-to-Use Culture Media

Hyderabad, India - BiomatiQ, a leading life science products distribution company, has marked a significant milestone with the inauguration of its state-of-the-art, fully automated production line for ready-to-use culture media.

4 min  |

BioSpectrum India May 2025
Bio Spectrum

Bio Spectrum

Can technology uplift the Indian BioSuppliers ecosystem?

The bioindustrial and biopharma segment have emerged as the two key sectors contributing majorly (82 per cent) to India's bioeconomy which stands at $165.7 billion in 2024.

5 min  |

BioSpectrum India May 2025
Bio Spectrum

Bio Spectrum

"Evolving regulatory requirements, heightened scrutiny from regulatory agencies, and geopolitical uncertainties pose challenges"

Strides Pharma Science demerged its Contract Development and Manufacturing Organisation (CDMO) business into OneSource Specialty Pharma Ltd, following approval by the National Company Law Tribunal (NCLT) in 2024.

5 min  |

BioSpectrum India May 2025
Bio Spectrum

Bio Spectrum

"The biosimilar developers are eagerly awaiting revised CDSCO regulations that might lead to simplification of the development pathway for biosimilars"

How has India's biosimilars landscape evolved over the past 25 years, and what have been the most significant milestones?

4 min  |

BioSpectrum India May 2025
Bio Spectrum

Bio Spectrum

"Govt initiatives and private sector investments are boosting adoption of NGS technologies for various applications"

Illumina, a global leader in DNA sequencing and array-based technologies, recently launched the MiSeq i100 and MiSeq i100 Plus Systems.

4 min  |

BioSpectrum India May 2025
Bio Spectrum

Bio Spectrum

Specialised Skill Development for GCCs in India

India is a key hub for Life Sciences and Healthcare (LSHC) Global Capability Centers (GCCs).

5 min  |

BioSpectrum India May 2025
Bio Spectrum

Bio Spectrum

Health Ministry releases national guidelines on medical oxygen management

The Ministry of Health and Family Welfare, Government of India, has released the National Guidelines on Medical Oxygen Management at a workshop held at the All India Institute of Medical Sciences (AIIMS), Delhi.

1 min  |

BioSpectrum India May 2025
Bio Spectrum

Bio Spectrum

Biomarkers in Kidney Health: Enhancing Early Detection and Treatments

Emerging biomarkers such as neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule-1 (KIM-1) have shown great potential in the early diagnosis of kidney injury.

4 min  |

BioSpectrum India May 2025
Bio Spectrum

Bio Spectrum

Mushrooming Generics.Turn Affordable Lifeline

The Indian pharmaceutical market is witnessing a dramatic transformation following the patent expiry of Empagliflozin (sold under the brand name Jardiance by Boehringer Ingelheim) on March 11, 2025, used for treatment of adults with type 2 diabetes mellitus, as an adjunct to diet and exercise to improve glycemic control and to reduce the risk of cardiovascular death in patients with established cardiovascular disease.

2 min  |

BioSpectrum India May 2025
Bio Spectrum

Bio Spectrum

Nagaland University announces undergraduate programme in Basic Sciences

Nagaland University is launching anew undergraduate programme in Basic Sciences from the Academic Year 2025-26.

1 min  |

BioSpectrum India May 2025
Bio Spectrum

Bio Spectrum

25 Transformative Years of BIOSIMILARS

BIOSIMILARS

6 min  |

BioSpectrum India May 2025
Bio Spectrum

Bio Spectrum

India's Biosimilars Revolution

The increasing incidence of chronic illnesses such as cancer, diabetes, and autoimmune disorders, which necessitate long-term biologic therapies, is driving the growth of the biosimilar market in India.

5 min  |

BioSpectrum India May 2025
Bio Spectrum

Bio Spectrum

Ankura Hospitals secures Rs 165 Cr funding from ADB

Hyderabad-based Ankura Hospitals, a leading healthcare provider specialising in super-specialty tertiary and quaternary care services for women and children, has secured Rs 165 crore in funding from the Asian Development Bank (ADB).

1 min  |

BioSpectrum India May 2025